Early diagnosis and individualized precise treatment are the keys to improve the survival rate and the quality of life and prolong the survival time of cancer patients. In the recent years,with the development of liquid biopsy technology,more and more novel tumor biomarkers have been found,showing potential in tumor diagnosis,prognostic judgment and treatment monitoring,and some indicators have been put into clinical practice. Future researches should focus on solving the problems that hinder the clinical transformation of novel tumor biomarkers,and promote more liquid biopsy indicators with clinical application prospects to optimize the diagnosis and treatment process of cancer patients,thereby reducing their disease burden.